famotidine

Generic: famotidine

Labeler: northwind health company, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name famotidine
Generic Name famotidine
Labeler northwind health company, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

famotidine 20 mg/1

Manufacturer
Northwind Health Company, LLC

Identifiers & Regulatory

Product NDC 51655-312
Product ID 51655-312_48eaefc6-3b41-0111-e063-6294a90abbd5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075805
Listing Expiration 2027-12-31
Marketing Start 2020-05-21

Pharmacologic Class

Established (EPC)
histamine-2 receptor antagonist [epc]
Mechanism of Action
histamine h2 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51655312
Hyphenated Format 51655-312

Supplemental Identifiers

RxCUI
310273
UNII
5QZO15J2Z8
NUI
N0000000151 N0000175784

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name famotidine (source: ndc)
Generic Name famotidine (source: ndc)
Application Number ANDA075805 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/1
source: ndc
Packaging
  • 20 TABLET in 1 BOTTLE, PLASTIC (51655-312-20)
  • 60 TABLET in 1 BOTTLE, PLASTIC (51655-312-25)
source: ndc

Packages (2)

51655-312-20 20 TABLET in 1 BOTTLE, PLASTIC (51655-312-20) 51655-312-25 60 TABLET in 1 BOTTLE, PLASTIC (51655-312-25)

Ingredients (1)

famotidine (20 mg/1)

Linked Drug Pages (1)

Famotidine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "48eaefc6-3b41-0111-e063-6294a90abbd5", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["5QZO15J2Z8"], "rxcui": ["310273"], "spl_set_id": ["ab1cdbbf-d838-020c-e053-2995a90a0f65"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "20 TABLET in 1 BOTTLE, PLASTIC (51655-312-20)", "package_ndc": "51655-312-20", "marketing_start_date": "20200522"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE, PLASTIC (51655-312-25)", "package_ndc": "51655-312-25", "marketing_start_date": "20200521"}], "brand_name": "Famotidine", "product_id": "51655-312_48eaefc6-3b41-0111-e063-6294a90abbd5", "dosage_form": "TABLET", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "51655-312", "generic_name": "Famotidine", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Famotidine", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "20 mg/1"}], "application_number": "ANDA075805", "marketing_category": "ANDA", "marketing_start_date": "20200521", "listing_expiration_date": "20271231"}